2014-2022 Impact of Pediatric Epilepsy Surgery on Health-Related Quality of Life
2019 An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy for Seizures in Patients with Rare Seizure Disorders Such as Epileptic Encephalopathies Including Dravet Syndrome and Lennox- Gastaut Syndrome
2022-2023 An Open-Label n Study of XEN496 in Pediatric Subjects with KCNQ2 Developmental and Epileptic EncephalopathyExtensio
2022-2023 A Phase 3 Study of Adjunctive XEN496 in Pediatric Subjects with KCNQ2 Developmental and Epileptic Encephalopathy
2023-2026 A 20-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Patients with Dravet Syndrome
Canadian Epilepsy Database and Registry (CEDAR)
2002 Partners in Care Award – BC Children’s Hospital
2005 First Recipient of the Annual Dr. Parminder Singh Award of Distinction for most valuable subspecialty consultant – BC Pediatric Society
2015 Clinical Practice and Advocacy Award from the Canadian League Against Epilepsy
2021 Clinician Practitioner Excellence in Leadership Award from the Pediatrics Chairs of Canada
Award of Distinction from Partners in Care - BC Children’s Hospital, 2006
BC Children’s Hospital Education Award - Education Day for Families, 2005
Every day, our researchers work towards breakthroughs to transform the lives of kids in BC and around the world. Learn about our latest innovations and advancements in child health.
When physical distancing measures were implemented in March 2020 during the first weeks of the COVID-19 pandemic, many pediatric hospital appointments were cancelled or rescheduled. Some clinics and hospital programs introduced or increased the use of virtual health — defined as the delivery of health care from anywhere with an internet or Wi-Fi connection using…
For children and families, a diagnosis of atypical cerebral palsy (CP) comes with as many questions as it does answers. CP is a broad category of disorders that affect a child’s movement and ability to communicate. Around two in every 1,000 children will develop the condition.
At BC Children’s, we are making discoveries that save lives and transform health care for children in our province and around the world. Our research portfolio includes basic, clinical, population, and public health research.
EXPLORE OUR RESEARCH
Sign up for compelling stories about innovative science, the doctors and researchers who turn ideas into discoveries and treatments, and the kids and families whose lives are changed.
BC Children's Hospital Research Institute operates on the ancestral and unceded territory of the Coast Salish peoples — xʷməθkʷəy̓əm (Musqueam), Sḵwx̱wú7mesh (Squamish), and Səl̓ílwətaʔ/Selilwitulh (Tsleil-Waututh) Nations. Further, this acknowledgement, gratitude, and respect extends to all of the First Nations communities on whose territories the Research Institute builds relationships and operates in British Columbia.
© 2026 BC Children’s Hospital Research Institute. All rights reserved.
Crafted with by Forge and Smith
